Key result
Dual transcatheter caval valves treat severe TR and refractory RHF in a single patient.
Why the study?
Torrential tricuspid regurgitation leads to heart failure and poor survival, and heterotopic transcatheter tricuspid replacement is offered for patients unsuitable for direct valve repair or replacement.
Case Report (n=1)
Demonstrates the use of heterotopic transcatheter implantation of two self-expanding valves in the venae cavae for a patient with torrential tricuspid regurgitation.
Torrential tricuspid regurgitation may lead to heart failure and poor survival and quality of life. Heterotopic transcatheter tricuspid replacement is increasingly offered to patients unsuitable for direct valve repair or replacement. We describe 1 patient treated by transcatheter implantation of 2 self-expanding valves in the venae cavae with a multimodality imaging approach. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Costa et al. (2022) conducted a case report in Severe tricuspid regurgitation and refractory right heart failure (n=1). Transcatheter implantation of 2 self-expanding valves in the venae cavae was evaluated. Transcatheter implantation of 2 self-expanding valves in the venae cavae was described in 1 patient with severe tricuspid regurgitation and refractory right heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: